Dr. Gevorg Sedrakyan

Dr. Jodi Segal is a professor of medicine at the Johns Hopkins University School of Medicine. She has joint appointments in health policy and management, and epidemiology at the Johns Hopkins Bloomberg School of Public Health. Dr. Segal is internationally recognized as a clinician-investigator in comparative effectiveness research and pharmacoepidemiology. She trains investigators to conduct research to advance Johns Hopkins Medicine as a learning health system. She serves as the associate director of the Center for Health Services and Outcomes Research (CHSOR) and the co-director of the Center for Drug Safety and Effectiveness (CDSE), both in the School of Public Health. Dr. Segal received a B.S. from The Pennsylvania State University. She earned her M.D. from the University of Pittsburgh School of Medicine and her M.P.H. from the Johns Hopkins Bloomberg School of Public Health. She completed her residency at the University of Chicago and a fellowship in general nternal medicine at Johns Hopkins. She is a member of Phi Beta Kappa and Alpha Omega Alpha. Dr. Segal is rated as an Advanced provider by MediFind in the treatment of Giant Papillary Conjunctivitis. Her top areas of expertise are Giant Papillary Conjunctivitis, Type 2 Diabetes (T2D), Vernal Keratoconjunctivitis, and Allergic Conjunctivitis.

Rahul Wadnerkar is a primary care provider, practicing in Internal Medicine in Leesburg, Virginia. Dr. Wadnerkar is rated as an Advanced provider by MediFind in the treatment of Giant Papillary Conjunctivitis. His top areas of expertise are Acute Cystitis, Bronchitis, COVID-19, and Multisystem Inflammatory Syndrome in Children (MIS-C). Dr. Wadnerkar is currently accepting new patients.

Farhad Jamali is a primary care provider, practicing in Internal Medicine in Glenn Dale, Maryland. Dr. Jamali is rated as a Distinguished provider by MediFind in the treatment of Giant Papillary Conjunctivitis. His top areas of expertise are Glucocorticoid-Remediable Aldosteronism, Hypertension, Familial Hypertension, and Subacute Combined Degeneration. Dr. Jamali is currently accepting new patients.